Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

Title

Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses

Authors

Keywords

Bladder cancer, Urothelial, Locally advanced, Perioperative chemotherapy, Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin, Gemcitabine and cisplatin

Journal

EUROPEAN UROLOGY

Volume -, Issue -, Pages -

Publisher

Elsevier BV

Online

2020-08-29

DOI

10.1016/j.eururo.2020.08.024